<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Prothena_Corporation_PLC</id>
	<title>Prothena Corporation PLC - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Prothena_Corporation_PLC"/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Prothena_Corporation_PLC&amp;action=history"/>
	<updated>2026-05-18T17:14:49Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=Prothena_Corporation_PLC&amp;diff=436681&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei Prothena Corporation PLC listata cu simbolul US.PRTA  ==Descriere companie== Prothena Corporation PLC (http://www.prothena.com/) is a late-stage clinical company. The Company is engaged in the protein dysregulation and a pipeline of therapeutics for devastating neurodegenerative and rare peripheral amyloid diseases. It is advancing a pipeline of therapeutic candidates around neurological dysfunction and the biology of misfolded proteins. The Company'...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Prothena_Corporation_PLC&amp;diff=436681&amp;oldid=prev"/>
		<updated>2024-09-18T18:22:47Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei Prothena Corporation PLC listata cu simbolul US.PRTA  ==Descriere companie== Prothena Corporation PLC (http://www.prothena.com/) is a late-stage clinical company. The Company is engaged in the protein dysregulation and a pipeline of therapeutics for devastating neurodegenerative and rare peripheral amyloid diseases. It is advancing a pipeline of therapeutic candidates around neurological dysfunction and the biology of misfolded proteins. The Company&amp;#039;...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei Prothena Corporation PLC listata cu simbolul US.PRTA&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
Prothena Corporation PLC (http://www.prothena.com/) is a late-stage clinical company. The Company is engaged in the protein dysregulation and a pipeline of therapeutics for devastating neurodegenerative and rare peripheral amyloid diseases. It is advancing a pipeline of therapeutic candidates around neurological dysfunction and the biology of misfolded proteins. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Birtamimab for the treatment of amyloid light-chain (AL) amyloidosis; prasinezumab for the treatment of Parkinson’s disease and other related synucleinopathies; and PRX004, for the treatment of Transthyretin amyloidosis (ATTR). The Company's pipeline also includes late-preclinical-stage programs targeting proteins implicated in neurological diseases including tau and amyloid beta (Aβ) for the treatment of Alzheimer’s disease and other neurodegenerative disorders, and TDP-43 for the treatment of amyotrophic lateral sclerosis.&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.PRTA&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre Prothena Corporation PLC (US.PRTA)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.PRTA&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.PRTA]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>